Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease

被引:17
|
作者
Facey, DA
Favaloro, EJ
Koutts, J
Berndt, MC
Hertzberg, MS [1 ]
机构
[1] Westmead Hosp, Dept Haematol, Westmead, NSW 2145, Australia
[2] Baker Inst, Hazel & Pip Appl Vasc Biol Lab, Prahran, Vic, Australia
关键词
VWF; VWD type 2B; mutation; recombinant;
D O I
10.1046/j.1365-2141.1999.01358.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2B non Willebrand's disease (VWD) is a variant in which the structurally abnormal von Willebrand factor (VWF) has an increased affinity for the platelet glycoprotein Ib-M-V complex. Spontaneous binding of type 2B VWF to platelets and their subsequent clearance from the plasma appear to account for the characteristic phenotype of type 2B VWD. Several type 2B mutations have been described and shown to be grouped along the amino edge of the beta sheet of the VWF Al domain. In this report we describe a novel missense mutation, Arg543Leu, in the VWF Al domain in three members of a family with type 2B VWD. We have expressed and characterized the corresponding recombinant mutant VWF in transiently transfected COS-7 cells. Relative to wild-type VWF, recombinant Arg543Leu VWF showed a similar multimer composition but exhibited binding to fixed platelets both in the presence and absence of ristocetin, confirming the ability of this mutation to permit spontaneous interaction of VWF with platelets. These studies are consistent with a recently proposed model in which the VWF-Al domain exists in either 'on' or 'off' states, with type 2B mutations switching VWF to an 'on' state to facilitate GPIb binding.
引用
收藏
页码:538 / 541
页数:4
相关论文
共 50 条
  • [41] von Willebrand factor alloantibodies in type 3 von Willebrand disease
    Kotnik, Barbara Faganel
    Strandberg, Karin
    Debeljak, Marusa
    Kitanovski, Lidija
    Jazbec, Janez
    Benedik-Dolnicar, Majda
    Bakija, Alenka Trampus
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2020, 31 (01) : 77 - 79
  • [42] Mutation causing von willebrand's disease in Scottish terriers
    Venta, PJ
    Li, JP
    Yuzbasiyan-Gurkan, V
    Brewer, GJ
    Schall, WD
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2000, 14 (01) : 10 - 19
  • [43] The contribution of a reduced von Willebrand factor survival in type 2 von Willebrand disease
    Gallinaro, L.
    Cattini, M. G.
    Pontara, E.
    Sartorello, F.
    Daidone, V
    Padrini, R.
    Bertomoro, A.
    Pagnan, A.
    Casonato, A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 843 - 843
  • [44] MOLECULAR CHARACTERIZATION OF A UNIQUE VON WILLEBRAND DISEASE VARIANT - A NOVEL MUTATION AFFECTING VON WILLEBRAND FACTOR FACTOR-VIII INTERACTION
    CACHERIS, PM
    NICHOLS, WC
    GINSBURG, D
    [J]. CLINICAL RESEARCH, 1991, 39 (02): : A327 - A327
  • [45] Mutation at Arg611 in the von Willebrand factor gene results in unclassifiable type 2 von Willebrand disease
    Nesbitt, IM
    Goodeve, AC
    Daly, ME
    Hampton, KK
    Makris, M
    Preston, FE
    Peake, IR
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : P2665 - P2665
  • [46] A novel mutation Gly1672->Arg in type 2A and a homozygous mutation in type 2B von Willebrand disease
    Hagiwara, T
    Inaba, H
    Yoshida, S
    Nagaizumi, K
    Arai, M
    Hanabusa, H
    Fukutake, K
    [J]. THROMBOSIS AND HAEMOSTASIS, 1996, 76 (02) : 253 - 257
  • [47] Type 2B Hiroshima: a variant of von Willebrand disease characterized by chronic thrombocytopenia and the presence of all von Willebrand factor multimers in plasma
    Takimoto, Y
    Imanaka, F
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 1999, 70 (02) : 127 - 131
  • [48] A novel candidate mutation in von Willebrand's disease type IIM
    Al-Homsi, AS
    Lambert, JF
    McQuain, C
    Mathai, J
    Taplin, ME
    Stewart, FM
    Quesenberry, PJ
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 284 - 284
  • [49] Identification of the elusive mutation causing the historical von Willebrand disease type IIC miami
    Schneppenheim, R.
    Ledford-Kraemer, M.
    Lavergne, J-M
    Marschalek, R.
    Montgomery, R.
    Obser, T.
    Oyen, F.
    Sadler, J. E.
    Schneppenheim, S.
    Budde, U.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 665 - 666
  • [50] How I treat type 2B von Willebrand disease
    Kruse-Jarres, Rebecca
    Johnsen, Jill M.
    [J]. BLOOD, 2018, 131 (12) : 1292 - 1300